Online-Trading Portfolio-Tracker Research Back-Office MF-Tracker
BSE Prices delayed by 5 minutes... << Prices as on Apr 30, 2024 >>   ABB 6542.35 [ 1.41 ]ACC 2531.3 [ 0.20 ]AMBUJA CEM 619.7 [ -1.60 ]ASIAN PAINTS 2877.05 [ 0.31 ]AXIS BANK 1166.15 [ 0.58 ]BAJAJ AUTO 8907.75 [ 1.69 ]BANKOFBARODA 281.6 [ 3.26 ]BHARTI AIRTE 1322.85 [ -0.78 ]BHEL 281.65 [ 1.75 ]BPCL 607.75 [ -1.77 ]BRITANIAINDS 4770.6 [ -0.63 ]CIPLA 1401.2 [ -0.45 ]COAL INDIA 454.3 [ 0.24 ]COLGATEPALMO 2824.7 [ -0.06 ]DABUR INDIA 507.55 [ 0.18 ]DLF 892 [ 0.65 ]DRREDDYSLAB 6205.1 [ -1.40 ]GAIL 209 [ -0.26 ]GRASIM INDS 2410.8 [ 0.95 ]HCLTECHNOLOG 1367.55 [ -1.41 ]HDFC 2729.95 [ -0.62 ]HDFC BANK 1517.05 [ -0.77 ]HEROMOTOCORP 4542.4 [ 1.88 ]HIND.UNILEV 2230.7 [ 0.17 ]HINDALCO 643.9 [ -0.97 ]ICICI BANK 1152.05 [ -0.58 ]IDFC 121.7 [ 0.04 ]INDIANHOTELS 576.75 [ -1.09 ]INDUSINDBANK 1515.6 [ 1.87 ]INFOSYS 1421.1 [ -0.97 ]ITC LTD 435.6 [ -0.55 ]JINDALSTLPOW 931.1 [ -1.15 ]KOTAK BANK 1623.75 [ -1.01 ]L&T 3594.15 [ -1.09 ]LUPIN 1645.45 [ 0.48 ]MAH&MAH 2156.3 [ 4.53 ]MARUTI SUZUK 12806.45 [ 0.87 ]MTNL 38.95 [ 3.56 ]NESTLE 2506.05 [ -0.18 ]NIIT 105.75 [ -1.90 ]NMDC 254.3 [ -0.24 ]NTPC 363.1 [ 0.00 ]ONGC 282.85 [ -0.16 ]PNB 141.1 [ 2.81 ]POWER GRID 301.65 [ 2.71 ]RIL 2931.15 [ 0.02 ]SBI 825.7 [ -0.05 ]SESA GOA 397.9 [ -2.07 ]SHIPPINGCORP 227.7 [ -2.04 ]SUNPHRMINDS 1502.3 [ -1.29 ]TATA CHEM 1072.3 [ -2.43 ]TATA GLOBAL 1107.85 [ 0.81 ]TATA MOTORS 1007.85 [ 0.74 ]TATA STEEL 164.95 [ -1.46 ]TATAPOWERCOM 449.1 [ 0.22 ]TCS 3822.6 [ -1.24 ]TECH MAHINDR 1261.95 [ -2.08 ]ULTRATECHCEM 9966.75 [ 0.05 ]UNITED SPIRI 1176 [ -0.39 ]WIPRO 462.3 [ -0.14 ]ZEETELEFILMS 147 [ -1.57 ] BSE NSE
You can view full text of the latest Auditor's Report for the company.

BSE: 532296ISIN: INE935A01035INDUSTRY: Pharmaceuticals

BSE   ` 1056.15   Open: 1073.80   Today's Range 1054.05
1080.45
-15.50 ( -1.47 %) Prev Close: 1071.65 52 Week Range 535.15
1098.00
Year End :2023-03 

Glenmark Pharmaceuticals Limited Basis for Opinion

Report on the Audit of Standalone Financial Statements

Opinion

We have audited the accompanying standalone financial statements of Glenmark Pharmaceuticals Limited (the Company'), which comprise the Balance Sheet as at 31 March 2023, the Statement of Profit and Loss (including other comprehensive income), the Statement of Cash Flows and the Statement of Changes in Equity for the year then ended, and a summary of the significant accounting policies and other explanatory information.

In our opinion and to the best of our information and according to the explanations given to us, the aforesaid standalone financial statements give the information required by the Companies Act, 2013 ('the Act') in the manner so required and give a true and fair view in conformity with the accounting principles generally accepted in India including Indian Accounting Standards ('Ind AS') prescribed under Section 133 of the Act, of the state of affairs of the Company as at 31 March 2023, and its profit (including other comprehensive income), its cash flows and the changes in equity for the year ended on that date.

We conducted our audit in accordance with the Standards on Auditing (SAs) specified under Section 143(10) of the Act. Our responsibilities under those standards are further described in the 'Auditor's Responsibilities for the Audit of the Standalone Financial Statements' section of our report. We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India ('ICAI') together with the ethical requirements that are relevant to our audit of the financial statements under the provisions of the Act and the rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion on the standalone financial statements.

Key Audit Matters

Key audit matters are those matters that, in our professional judgement, were of most significance in our audit of the standalone financial statements for the year ended 31 March 2023. These matters were addressed in the context of our audit of the standalone financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.

We have determined the matters described below to be the key audit matters to be communicated in our report.

Key audit matter

How our audit addressed the key audit matter

Impairment of investments in and loss allowances of loans

Our audit included, but was not limited to, the following

given to subsidiaries [Refer note 5(i)(A) (a) & 5(i) (F) and 5(ii)

procedures:

of the standalone financial statements]

• Assessed the appropriateness of accounting policy in

As at 31 March 2023, the Company has investments in

respect of impairment and loss allowances in accordance

subsidiaries of H102,894.43 million (net of provision for

with Ind AS.

impairment) and has loans to subsidiaries of H68,740.68 million.

• Obtained understanding of management's process for

Investments in subsidiaries are accounted for at cost less

loss allowances and for identification of indicators of

impairment loss, if any. Loans given to subsidiaries are

impairment. Evaluated the design and tested the operating

measured at amortised cost.

effectiveness of internal controls over loss allowances and

Loans are assessed for loss allowances and investments are

impairment assessment process.

assessed for impairment annually or earlier if indicator exists.

• With the assistance of our internal valuation specialists

If indicators exist, the loss allowances of loans and impairment

evaluated the reasonableness of the valuation

of the investments are estimated in order to determine the

methodologies and discount rates used by the

extent of loss allowances and impairment losses, if any. Any

management to determine the recoverable values.

such losses are recognised in Statement of Profit and Loss.

• Evaluated the reasonableness of the management's

Management judgement is required in assessing impairment

estimates and judgement based on our understanding of

indicators and recoverable amount for impairment testing.

the business of the respective subsidiaries, past results

The recoverable amounts have been determined by the management using discounted cash flow valuation method.

and external factors.

Key audit matter

How our audit addressed the key audit matter

Key assumptions underpinning management's assessment

• Tested the mathematical accuracy of the management

of the recoverable amounts include but are not limited to

workings with regard to cash flows, sensitivity analysis

projection of future cash flows, revenue growth rates, terminal values operating profit margins, estimated future operating

and loss allowances.

capital expenditure, external market conditions and discount

• Performed sensitivity analysis around aforesaid key

rates.

assumptions to assess the effect of reasonably possible variations on the estimated recoverable amounts of

Based on the assessment as above, no impairment/loss

investments in and loans receivable from respective

allowance has been recognised during the year ended 31 March 2023.

We determined impairment of investments in and loss allowances of loans given to subsidiaries as a key audit matter since these assessments are complex and involve significant management estimation and judgement.

subsidiaries.

Litigations

[Refer note 30 of the standalone financial statements]

Our audit included, but was limited to the following procedures: • Evaluated the design and tested the operating

The Company is involved in various legal proceedings including

effectiveness of controls in respect of the identification

product liability, contracts, employment claims, Department of

and evaluation of litigations, the recording/reassessment

Justice (DOJ) investigations, anti-trust and other regulatory matters relating to the conduct of its business.

of the related liabilities, provisions, and disclosures.

• Obtained a list of litigations from the Company's in-house

The Company assesses the need to make provision or to

legal counsel; identified material litigations from the

disclose contingent liability on a case-to-case basis considering the underlying facts of each litigation.

aforementioned list and performed inquiries with the said counsel; obtained and read the underlying documents to assess the assumptions used by management in arriving

The eventual outcome of the litigations is uncertain and

at the conclusions.

estimation at balance sheet date involves extensive judgement

• Circulated, obtained, and read legal confirmations from

of management including input from legal counsel due

Company's external legal counsels in respect of material

to complexity of each litigation. Adverse outcomes could significantly impact on the Company's reported results and

litigations and considered that in our assessment.

balance sheet position.

• Verified the disclosures related to provisions and contingent liabilities in the standalone Ind AS financial

Considering the judgement involved in determining the need

statements to assess consistency with underlying

to make a provision or disclose as contingent liability, the matter is considered a key audit matter.

documents.

Information other than the Financial Statements and Auditor’s Report thereon

The Company's Board of Directors is responsible for the other information. The other information comprises the information included in the Annual Report but does not include the standalone financial statements and our auditor's report thereon.

Our opinion on the standalone financial statements does not cover the other information and we do not express any form of assurance conclusion thereon.

In connection with our audit of the standalone financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the standalone financial statements, or our knowledge obtained in the audit or otherwise appears to be materially misstated. If, based on the work we have performed, we conclude that there is a material misstatement of this other information; we are required to report that fact. We have nothing to report in this regard.

Management’s and Board of Directors’ Responsibilities for the Standalone Financial Statements

The Company's Management and Board of Directors is responsible for the matters stated in Section 134(5) of the Act with respect to the preparation of these standalone financial statements that give a true and fair view of the financial position, financial performance including other comprehensive income, cash flows and changes in equity of the Company in accordance with the accounting principles generally accepted in India, including the Indian Accounting Standards (Ind AS) specified under Section 133 of the Act. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding of the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgements and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error.

In preparing the standalone financial statements, the Management and the Board of Directors are responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Board of Directors either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

The Board of Directors is also responsible for overseeing the Company's financial reporting process.

Auditor’s Responsibilities for the Audit of the Standalone Financial Statements

Our objectives are to obtain reasonable assurance about whether the standalone financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these standalone financial statements.

As part of an audit in accordance with SAs, we exercise professional judgement and maintain professional skepticism throughout the audit. We also:

• Identify and assess the risks of material misstatement of the standalone financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

• Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under Section 143(3) (i) of the Act, we are also responsible for expressing our opinion on whether the Company has in place adequate internal financial controls with reference to standalone financial statements and the operating effectiveness of such controls.

• Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the Management and the Board of Directors.

• Conclude on the appropriateness of the Management's and the Board of Directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the standalone financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern.

• Evaluate the overall presentation, structure, and content of the standalone financial statements, including the disclosures, and whether the standalone financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

Materiality is the magnitude of misstatements in the standalone financial statements that, individually or in aggregate, makes it probable that the economic decisions of a reasonably knowledgeable user of the standalone financial statements may be influenced. We consider quantitative materiality and qualitative factors in (i) planning the scope of our audit work and in evaluating the results of our work; and (ii) to evaluate the effect of any identified misstatements in the standalone financial statements.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the standalone financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditor's report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

Report on Other Legal and Regulatory Requirements

1. As required by the Companies (Auditor's Report) Order, 2020 ('the Order') issued by the Central Government of India in terms of Section 143(11) of the Act, we give in the “Annexure A" a statement on the matters specified in paragraphs 3 and 4 of the Order.

2. As required by Section 143(3) of the Act, based on our audit, we report that:

a) We have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary for the purpose of our audit of the accompanying standalone financial statements;

b) In our opinion, proper books of account as required by law have been kept by the Company so far as it appears from our examination of those books;

c) The balance sheet, statement of profit and loss (including other comprehensive income), statement of cash flows and statement of changes in equity dealt with by this report are in agreement with the books of account;

d) In our opinion, the aforesaid standalone financial statements comply with Ind AS specified under Section 133 of the Act;

e) On the basis of the written representations received from the directors and taken on record by the Board of Directors, none of the directors is disqualified as on 31 March 2023 from being appointed as a director in terms of Section 164(2) of the Act; and

f) With respect to adequacy of internal financial controls with reference to standalone financial statements of the Company and the operating effectiveness of such controls, refer our separate report in Annexure B. Our report expresses an unmodified opinion on the adequacy and operating effectiveness of the Company's internal financial controls with respect to standalone financial statements.

3. With respect to the other matters to be included in the Auditor's Report in accordance with rule 11 of the Companies (Audit and Auditors) Rules, 2014 (as amended), in our opinion and to the best of our information and according to the explanations given to us:

i. The Company has disclosed the impact of pending litigations as at 31 March 2023 on its financial position in its standalone financial statements - refer Note 30(i) to the standalone financial statements.

ii. The Company did not have any long-term contracts including derivative contracts for which there were any material foreseeable losses.

iii. There has been no delay in transferring amounts, required to be transferred, to the Investor Education and Protection Fund by the Company during the year ended 31 March 2023.

iv. a) The Management has represented that, to the best of its knowledge and belief no funds have been advanced, loaned, invested by the Company to or in any other person or entity, including foreign entities (“Intermediaries"), with the understanding, whether recorded in writing or otherwise, that the Intermediary shall, whether, directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Company (“Ultimate Beneficiaries") or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.

b) The Management has represented that, to the best of its knowledge and belief, no funds have been received by the Company from any person or entity, including foreign entities (“Funding Parties"), with the understanding, whether recorded in writing or otherwise, that the Company shall, whether, directly or indirectly, lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Funding Party (“Ultimate Beneficiaries") or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.

c) Based on audit procedures that has been considered reasonable and appropriate in the circumstances, nothing has come to our notice that has caused us to

believe that the representations under sub-clause (i) and (ii) of Rule 11(e), as provided under sub clause (a) & (b) above, contain any material misstatement.

v. The final dividend proposed in the previous year, declared, and paid by the Company during the year is in accordance with Section 123 of the Act, as applicable.

As stated in note 36 to the financial statements, the Board of Directors of the Company have proposed final dividend for the year which is subject to the approval of the members at the ensuing Annual General Meeting. The dividend declared is in accordance with Section 123 of the Act to the extent it applies to declaration of dividend.

vi. As proviso to rule 3(1) of the Companies (Accounts) Rules, 2014 for maintaining books of accounts using the accounting software which has a feature of recording audit trail (edit log) facility is applicable for the Company only with effect from 1 April 2023, reporting under Rule 11(g) of the Companies (Audit and Auditors) Rules, 2014 is not applicable.

4. With regards to the other matters to be included in the Auditor's Report in accordance with the requirement of Section 197(16) of the Act, as amended in our opinion and to the best of our information and according to the explanations given to us, the remuneration paid/ provided by the Company to its directors during the current year is in accordance with the provisions of Section 197 of the Act.

For Suresh Surana & Associates LLP

Chartered Accountants

Firm's Registration No.: 121750W/W100010

Vinodkumar Varma Partner

Membership No. 105545 UDIN: 23105545BGTYYB5489

Place: Mumbai Date: 19 May 2023